Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis

Efforts have been made to identify factors influencing clinical response in patients with atopic dermatitis (AD) treated with dupilumab. A retrospective single-center observational study was carried out by analyzing data from 492 patients aged 12 years and older with moderate-to-severe AD. The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrucci, Silvia, Casazza, Giovanni, Zussino, Martina, Tavecchio, Simona, Marzano, Angelo V., Tedeschi, Micol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607560/
https://www.ncbi.nlm.nih.gov/pubmed/37892713
http://dx.doi.org/10.3390/jcm12206575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607560/
https://www.ncbi.nlm.nih.gov/pubmed/37892713
http://dx.doi.org/10.3390/jcm12206575

Ejemplares similares